Robert M. OʼBryan
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
-
- Sarcoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Breast Cancer Treatment Studies 10
- Oncology 14
- Pancreatic and Hepatic Oncology Research 3
- Cancer Treatment and Pharmacology 3
- Co-authors
- Laurence H. Baker (6 shared papers)Jeffrey A. Gottlieb (5 shared papers)Saul E. Rivkin (10 shared papers)Robert W. Talley (4 shared papers)James K. Luce (2 shared papers)Gianni Bonadonna (1 shared paper)Barth Hoogstraten (6 shared papers)S P Balcerzak (4 shared papers)
- Journals
- Cancer (13 papers)Journal of Clinical Oncology (4 papers)Investigational New Drugs (3 papers)Journal of Neuro-Oncology (3 papers)Radiology (3 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Robert M. OʼBryan
49 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 68
- Oncology 429
- Pulmonary and Respiratory Medicine 573
- Cancer Research 207
- Genetics 117
- Toxicology 43
Countries citing papers authored by Robert M. OʼBryan
This map shows the geographic impact of Robert M. OʼBryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. OʼBryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. OʼBryan more than expected).
Fields of papers citing papers by Robert M. OʼBryan
This network shows the impact of papers produced by Robert M. OʼBryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. OʼBryan. The network helps show where Robert M. OʼBryan may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert M. OʼBryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1973 | 365 | |
| 2 | 1977 | 335 | |
| 3 | Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. | 1976 | 122 |
| 4 | 1987 | 72 | |
| 5 | 1983 | 66 | |
| 6 | 1983 | 65 | |
| 7 | 1974 | 60 | |
| 8 | 2002 | 54 | |
| 9 | 1967 | 51 | |
| 10 | 1978 | 46 | |
| 11 | 1986 | 46 | |
| 12 | 1979 | 45 | |
| 13 | 1983 | 42 | |
| 14 | 1983 | 40 | |
| 15 | 1993 | 40 | |
| 16 | Limited squamous cell carcinoma of the lung: a Southwest Oncology Group randomized study of radiation with or without doxorubicin chemotherapy and with or without levamisole immunotherapy. | 1982 | 28 |
| 17 | 1995 | 28 | |
| 18 | 1984 | 23 | |
| 19 | Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study. | 1985 | 23 |
| 20 | 1990 | 23 |
About Robert M. OʼBryan
Robert M. OʼBryan is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Toxicology, having authored 50 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), Cancer therapeutics and mechanisms (7 papers), Sarcoma Diagnosis and Treatment (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Glioma Diagnosis and Treatment (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Oncology (429 citations), Pulmonary and Respiratory Medicine (573 citations), Cancer Research (207 citations), Genetics (117 citations) and Toxicology (43 citations). Robert M. OʼBryan has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Laurence H. Baker, Jeffrey A. Gottlieb, Saul E. Rivkin, Robert W. Talley, James K. Luce, Gianni Bonadonna, Barth Hoogstraten, S P Balcerzak, Thomas E. Moon and S. E. Salmon. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Investigational New Drugs, Journal of Neuro-Oncology and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.